Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
0.6419
-0.0111 (-1.70%)
Aug 28, 2026, 4:00 PM EDT - Market closed

Standard BioTools Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
84.91-74.9-138.89-74.66-190.1-59.24
Depreciation & Amortization
9.5610.9816.8615.1815.033.65
Other Amortization
-----12.54
Loss (Gain) From Sale of Assets
-172.29-----
Asset Writedown & Restructuring Costs
----3.53-
Loss (Gain) From Sale of Investments
-0.96-2.04-7.44-1.26-0.67-
Stock-Based Compensation
27.0929.6131.7313.1214.8816.1
Other Operating Activities
14.546.98-16.536.386.562.81
Change in Accounts Receivable
0.33-1.368.97-2.991.066.73
Change in Inventory
0.21-11.52-9.88-4.91-8.47-4.78
Change in Accounts Payable
2.042.44-12.981.62-2.781.28
Change in Unearned Revenue
-29.81-1.31-4.140.88-3.47-3.21
Change in Other Net Operating Assets
-11.744.88-11.163.33-4.95-19.95
Operating Cash Flow
-80.3-74.34-143.45-43.29-89.37-44.06
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2.28-8.3-8.36-2.83-3.83-13.26
Cash Acquisitions
--278.65---
Investment in Securities
-190.1640.7192.8823.07-84.3-
Other Investing Activities
-5-5---1.32
Investing Cash Flow
190.7827.41363.1720.24-88.13-11.95

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-----6.84
Long-Term Debt Issued
----2510
Total Debt Issued
----2516.84
Long-Term Debt Repaid
---63.19-2.08-6.84-0.5
Net Debt Issued (Repaid)
---63.19-2.0818.1616.34
Issuance of Common Stock
0.941.052.070.830.921.49
Repurchase of Common Stock
-0.61-0.48-40.95-5.55-0.77-1.79
Other Financing Activities
---0.55--12.55-0.08
Financing Cash Flow
0.330.57-102.62-6.81230.7615.96

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.110.84-0.790.03-0.4-0.02
Net Cash Flow
110.91-45.52116.32-29.8352.86-40.07

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-82.58-82.65-151.81-46.12-93.2-57.33
Free Cash Flow Growth
------
Free Cash Flow Margin
-97.61%-96.85%-166.81%-43.37%-95.15%-43.90%
Free Cash Flow Per Share
-0.21-0.22-0.43-0.58-1.19-0.76
Levered Free Cash Flow
176.58-171.83-54.61-9.27-39.97-31.59
Unlevered Free Cash Flow
176.6-171.82-52.54-6.42-37.26-29.82

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.010.023.093.823.493.15
Cash Income Tax Paid
--0.070.610.80.312.09
Change in Working Capital
-39.09-44.98-29.2-1.97-18.6-19.93
SEC Filings: 10-K · 10-Q